Why a Biotech ETF Might Cure Your Portfolio in 2023

While the headlines have focused on a crypto winter, it hasn’t exactly been an easy year for biotech. The sector that blossomed amid a global pandemic has struggled with the pandemic easing and rates rising. But with a recession looming for equities overall, innovations accessible in a biotech ETF for 2023 like the ARK Genomic [...] The post Why a Biotech ETF Might Cure Your Portfolio in 2023 appeared first on ETF Trends .